INE963 / Novartis  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
INE963 / Novartis
NCT04896632: Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants

Terminated
1
64
Europe
INE 963, Placebo
Novartis Pharmaceuticals
Healthy Volunteers
11/22
11/22

Download Options